Transcranial Sonography as a Diagnostic Tool for Depressive Disorders
Journal of Ultrasound in Medicine · 2023-03 · 42 (3) · 687-699
DOI: 10.1002/jum.16081 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Ultrasound in Medicine, online erschienen am 10.08.2022. Verfasst von Yanping Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of neuroelectrophysiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Depressive Disorder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Science and Technology Program of the Jiangxi Provincial Health Commission.
Abstract (Originalsprache)
Background
Transcranial sonography (TCS) is an available and noninvasive neuroimaging method that has been found to reduce the echogenicity of the brainstem raphe (BR) in patients with depression. Applying the criteria of the Diagnostic and Statistical Manual of Mental Disorders‐IV (DSM‐IV), we performed a meta‐analysis of the diagnostic accuracy of TCS.
Methods
A systematic search was conducted in PubMed, EMBASE, The Cochrane Library, and Web of Science. The databases were searched from inception to December 2021. The quality of the included literature was assessed using the QUADAS‐2. Heterogeneity analysis was performed. A summary receiver operating characteristic (SROC) curve was generated to evaluate the diagnostic accuracy of TCS.
Results
We included 12 studies with 809 patients. The pooled sensitivity was 0.66 (95% confidence interval [CI]: 0.61–0.71), and the specificity was 0.84 (95% CI: 0.80–0.87). The combined positive likelihood ratio (LR) was 3.84 (95% CI: 2.68–5.51), the negative LR was 0.41 (95% CI: 0.29–0.57), and the diagnostic odds ratio (DOR) was 11.45 (95% CI: 5.57–23.02). The area under the curve (AUC) of the plotted SROC curve was 0.86 (95% CI: 0.83–0.89). The meta‐regression and subgroup analyses found no source of heterogeneity.
Conclusion
TCS has high potential and efficacy in diagnosing depression and may be a reasonable test to perform clinically for the assessment of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of neuroelectrophysiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Förderung
- Science and Technology Program of the Jiangxi Provincial Health Commission
Zitieren
APA
Li, Y., Cao, Q., Hou, Z., Tang, B., & Shen, Y. (2023). Transcranial Sonography as a Diagnostic Tool for Depressive Disorders. Journal of Ultrasound in Medicine, 42(3), 687-699. https://doi.org/10.1002/jum.16081
Vancouver
Li Y, Cao Q, Hou Z, Tang B, Shen Y. Transcranial Sonography as a Diagnostic Tool for Depressive Disorders. Journal of Ultrasound in Medicine. 2023;42(3):687-699. doi:10.1002/jum.16081
BibTeX
@article{Li2023,
author = {Li, Yanping and Cao, Qian and Hou, Zhuo and Tang, Boji and Shen, Yu},
title = {Transcranial Sonography as a Diagnostic Tool for Depressive Disorders},
journal = {Journal of Ultrasound in Medicine},
year = {2023},
volume = {42},
number = {3},
pages = {687--699},
doi = {10.1002/jum.16081}
}
EUVIMED